Expression of URG4/URGCP, Cyclin D1, Bcl-2, and Bax genes in retinoic acid treated SH-SY5Y human neuroblastoma cells

Wspolczesna Onkologia

Volumn 17, Issue 4, 2013, Pages 346-349

  Dodurga, Yavuz ^a   Gundogdu, Gulsah ^a   Koc, Tugba ^a   Yonguc, G Nilufer ^a   Kucukatay, Vural ^a   Satiroglu Tufan, N Lale ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Human neuroblastoma cells; Retinoic acid; SHSY5Y; URG4 URGCP

Indexed keywords

CYCLIN D1; PROTEIN BAX; PROTEIN BCL 2; REAGENT; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEURITE; NEUROBLASTOMA CELL; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

EID: 84886077508     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2013.34634     Document Type: Article

References (26)

1. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999; 17: 2264-79. (Pubitemid 29318861)
2. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004; 328: 1-16. (Pubitemid 38352876)
3. Morriss-Kay GM, Ward SJ. Retinoids and mammalian development. Int Rev Cytol 1999; 188: 73-131. (Pubitemid 129751066)
4. Meyer M, Sonntag-Buck V, Keaveney M, Stunnenberg HG. Retinoiddependent transcription: the RAR/RXR-TBP-EIA/EIA-LA connection. Biochem Soc Symp 1996; 62: 97-109.
5. Levi F, Franceschi S, Negri E, La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer 1993; 71: 3575-81. (Pubitemid 23152668)
6. Negri E, La Vecchia C, Franceschi S, Levi F, Parazzini F. Intake of selected micronutrients and the risk of endometrial carcinoma. Cancer 1996; 77: 917-23. (Pubitemid 26061286)
7. Langner E, Rzeski W. Dietary derived compounds in cancer chemoprevention. Wspolczesna Onkol 2012; 16: 394-400.
8. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982; 68: 589-96. (Pubitemid 12078843)
9. Feyles V, Dixon WT, Sikora LK, McGarry RC, Jerry LM. Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers. Cancer Immunol Immunother 1991; 32: 261-72.
10. Barletta E, Mugnai G, Ruggieri S. Inverse relationship between invasiveness and differentiative capacity in different human neuroblastoma cell lines. Int J Cancer 1997; 70: 556-60. (Pubitemid 27149640)
11. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19. (Pubitemid 23259742)
12. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995; 11: 101-5.
13. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17: 3878-85. (Pubitemid 28333974)
14. Tufan NL, Lian Z, Liu J, et al. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia 2002; 4: 355-68. (Pubitemid 34755846)
15. Park SG, Chung C, Kang H, Kim JY, Jung G. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. J Biol Chem 2006; 281: 31770-7. (Pubitemid 46041442)
16. Song J, Xie H, Lian Z, et al. Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia 2006; 8: 995-1002.
17. Huang J, Zhu B, Lu L, et al. The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis. Pathology 2009; 41: 149-54.
18. Satiroglu-Tufan NL, Dodurga Y, Gok D, Cetinkaya A, Feitelson MA. RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cells. Genet Mol Res 2010; 9: 1557-67.
19. Sharma M, Sharma P, Pant HC. CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells. J Neurochem 1999; 73: 79-86. (Pubitemid 29289113)
20. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Ceña V, Gallego C, Comella JX. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 2000; 75: 991-1003. (Pubitemid 30660487)
21. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003; 22: 7305-15. (Pubitemid 37487162)
22. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-73. (Pubitemid 29480654)
23. van Noesel MM, Versteeg R. Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 2004; 325: 1-15. (Pubitemid 38030371)
24. Reynolds CP, Lemons RS. Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 2001; 15: 867-910. (Pubitemid 34026975)
25. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-6. (Pubitemid 28406819)
26. Garcia I, Martinou I, Tsujimoto Y, Martinou JC. Prevention of programmed cell death of sympathetic neurons by the Bcl-2 protooncogene. Science 1992; 258: 302-4.